Keywords: fda, grants, fast, track, review, arixtra, sanofi-synthelabo

FDA grants fast track review to Arixtra

Article | 27 April 2001

Sanofi-Synthelabo and partner Organon have been awarded a six-monthpriority "fast-track" review of Arixtra (fondaparinux sodium; formerly Org31540/ SR90107) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Organon

Go to company listing

Related Drugs

Arixtra

fondaparinux

Go to drug listing